What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Internal medicine, Incidence, Risk factor, Prospective cohort study and Endocrinology.
The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Cardiology.
The various areas that Lars Janzon examines in his Cardiology study include Fibrinogen and Blood pressure.
His Incidence study combines topics in areas such as Gynecology and Surgery.
His work deals with themes such as Stroke, Odds ratio and Vital capacity, FEV1/FVC ratio, which intersect with Risk factor.
His Prospective cohort study research is multidisciplinary, incorporating elements of Epidemiology, Gerontology, Cohort and Environmental health.
His most cited work include:
- Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. (796 citations)
- Design and feasibility (491 citations)
- The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. (386 citations)
What are the main themes of his work throughout his whole career to date?
Lars Janzon mainly investigates Internal medicine, Surgery, Incidence, Risk factor and Cardiology.
His Internal medicine study frequently links to other fields, such as Endocrinology.
His research in Surgery intersects with topics in Stenosis, Disease and Population study.
His Incidence research integrates issues from Epidemiology, Demography, Quartile, Stroke and Gynecology.
His studies deal with areas such as Odds ratio, Prospective cohort study and Lung cancer as well as Risk factor.
His Cardiology study combines topics from a wide range of disciplines, such as Asymptomatic and Vascular disease.
He most often published in these fields:
- Internal medicine (55.45%)
- Surgery (31.36%)
- Incidence (31.36%)
What were the highlights of his more recent work (between 2003-2009)?
- Internal medicine (55.45%)
- Incidence (31.36%)
- Risk factor (28.18%)
In recent papers he was focusing on the following fields of study:
Lars Janzon spends much of his time researching Internal medicine, Incidence, Risk factor, Surgery and Stroke.
His Internal medicine study frequently draws connections between adjacent fields such as Cardiology.
Lars Janzon has researched Incidence in several fields, including Epidemiology, Demography, Confidence interval, Gynecology and Confounding.
His Risk factor research includes elements of Odds ratio, Diabetes mellitus, European Prospective Investigation into Cancer and Nutrition, Cohort and Vascular disease.
His work in Surgery addresses subjects such as Disease, which are connected to disciplines such as Significant difference, Middle age and Common carotid artery.
His Stroke study combines topics from a wide range of disciplines, such as Menopause, Physical therapy, Case-control study and Blood pressure.
Between 2003 and 2009, his most popular works were:
- Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study (289 citations)
- Incident coronary events and case fatality in relation to common carotid intima-media thickness. (210 citations)
- Complement C3 Is a Risk Factor for the Development of Diabetes: A Population-Based Cohort Study (183 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Internal medicine, Risk factor, Incidence, Stroke and Relative risk.
His studies deal with areas such as Diabetes mellitus, Endocrinology and Cardiology as well as Internal medicine.
In Risk factor, Lars Janzon works on issues like Odds ratio, which are connected to Cancer.
His Incidence research is multidisciplinary, relying on both Intracerebral hemorrhage, Breast cancer, Gynecology and Cerebral infarction.
The various areas that Lars Janzon examines in his Stroke study include Blood pressure, Myocardial infarction, Case fatality rate and Vascular disease.
The study incorporates disciplines such as Demography and Cohort study in addition to Relative risk.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
